What parameters are measured by a Pulmonary Artery Catheter (PAC) in critically ill patients?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 22, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Pulmonary Artery Catheter Measurements

The pulmonary artery catheter directly measures pressures in the superior vena cava, right atrium, right ventricle, and pulmonary artery, along with cardiac output, and modern catheters can also measure mixed venous oxygen saturation, right ventricular end-diastolic volume, and right ventricular ejection fraction. 1

Direct Measured Parameters

The PAC provides several directly measured hemodynamic values:

  • Right atrial pressure (RAP): Normal values 2-8 mmHg, reflecting right ventricular preload, though it rarely correlates with left atrial pressures in acute heart failure patients 2
  • Right ventricular pressure: Systolic values normally 15-30 mmHg and end-diastolic values 2-8 mmHg 2
  • Pulmonary artery pressure: Systolic 15-30 mmHg, diastolic 4-12 mmHg, mean 9-18 mmHg 2
  • Pulmonary capillary wedge pressure (PCWP): Normal values <12 mmHg, estimating left ventricular filling pressure 1, 2
  • Cardiac output: Measured via thermodilution, with modern catheters providing semi-continuous measurements 1
  • Mixed venous oxygen saturation (SvO₂): Provides estimate of oxygen transport and body oxygen consumption/delivery ratio 1

Calculated/Derived Parameters

From the directly measured values, the PAC enables calculation of:

  • Cardiac index (CI): Cardiac output divided by body surface area, with normal values >2.5 L/min/m² (decreased if <2.2 L/min/m²) 2
  • Pulmonary vascular resistance (PVR): Calculated as (mean PAP - PCWP) / CO, with normal values <2-3 Wood units 2
  • Systemic vascular resistance (SVR): Calculated as (MAP - RAP) / CO, with normal values 800-1200 dynes·s·cm⁻⁵ 2

Critical Measurement Pitfalls

PCWP is not an accurate reflection of left ventricular end-diastolic pressure in patients with mitral stenosis, aortic regurgitation, ventricular interdependence, high airway pressure, or stiff left ventricle (due to left ventricular hypertrophy, diabetes, fibrosis, inotropes, obesity, or ischemia). 1, 2

Additional measurement limitations include:

  • Severe tricuspid regurgitation can overestimate or underestimate cardiac output measured by thermodilution 1, 2
  • Pressures must be measured at end-expiration during spontaneous breathing when intrathoracic pressure approaches atmospheric 2
  • Transducer zeroing must be performed at the mid-thoracic line for accurate pressure readings 2
  • Positive end-expiratory pressure (PEEP) ventilation affects CVP and other pressure measurements 1

Clinical Application Algorithm

The European Society of Cardiology provides a therapeutic approach based on PAC measurements 1:

  • Low CI (<2.2 L/min/m²) + Low PCWP (<14 mmHg) + SBP >85 mmHg: Indicates hypovolemia; therapy is fluid loading 2
  • Low CI + High PCWP (18-20 mmHg) + SBP >85 mmHg: Indicates cardiogenic shock with adequate pressure; use vasodilators (nitroprusside, nitroglycerin) and IV diuretics 1, 2
  • Low CI + High PCWP + Low SBP: Indicates severe cardiogenic shock; use inotropic agents (dobutamine, dopamine) and vasoconstrictive inotropes if SBP is critically low 1, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Pulmonary Artery Catheter Monitoring Parameters and Interpretation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What is the primary indication for pulmonary artery (PA) balloon catheterization?
Is the use of a pulmonary artery (PA) catheter recommended in patients with severe mitral regurgitation, severe tricuspid regurgitation, and severe pulmonary arterial hypertension?
When are pulmonary artery catheters (PACs) recommended for use in critically ill patients?
What parameters can be monitored with a Pulmonary Artery Catheter (PAC) and how are they interpreted?
How are PA (Pulmonary Artery) catheter pressures interpreted?
What are the prescribing laws for phentermine (a controlled substance) in patients with a body mass index (BMI) of 30 or higher or those with a BMI of 27 or higher and weight-related conditions such as hypertension, type 2 diabetes mellitus, or hypercholesterolemia?
What medication is most effective in controlling insulin resistance in non-diabetic individuals, and what are the roles of Inositol, Metformin, and GLP-1 (Glucagon-Like Peptide-1) agonists in managing insulin resistance?
What is the best pharmacological intervention for a 50-year-old male with hypercholesterolemia (elevated total cholesterol), low High-Density Lipoprotein (HDL) cholesterol, hypertriglyceridemia (high triglycerides), and high Low-Density Lipoprotein (LDL) cholesterol, who is otherwise healthy?
Is it normal for a patient with obsessive-compulsive disorder (OCD) to experience a setback with increased anxiety after two good days, given recent rapid dosage changes of their medication, and when can stabilization be expected, particularly in terms of improvement in symptoms such as sticky and racing thoughts?
Is it reasonable to start pioglitazone (thiazolidinedione) 7.5 mg once daily in a patient with diabetes, hemoglobin A1c (HbA1c) of 7.8%, on Tresiba (insulin degludec) 20 units once daily, metformin 2.5 grams daily, empagliflozin (SGLT2 inhibitor) 25 mg once daily, and valsartan (angiotensin II receptor antagonist) 80 mg twice daily, with no signs or symptoms of heart failure (HF) and no established atherosclerotic cardiovascular disease (ASCVD)?
How to manage a patient with supraventricular tachycardia (SVT)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.